Vivo Capital Fund VIII, L.P., 10% Owner at Menlo Therapeutics, Inc. (MNLO), bought 2,642,668 shares at $17.00 ($5.0M) on 2018-01-25, disclosed to the SEC on 2018-01-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.00 | 35,686 | $607K | 12.1% |
| 2 | $17.00 | 258,432 | $4.4M | 87.9% |
| 3 | $0.00 | 2,348,550 | $0 | 0.0% |
| Total | $1.89 avg | 2,642,668 | $5.0M | 100% |
| Filing → |
| CRNX | SELL | 2020-02-06 | $606K | — | Filing → |
| CRNX | BUY | 2018-07-20 | $9.8M | — | Filing → |
| BPMX | BUY | 2017-05-01 | $2.0M | — | Filing → |